SynthesisInternational journal of molecular sciences2022

Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.

Giovanni Maria Iannantuono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.